Drug resistant tuberculosis (MDR-TB)

Drug resistance tuberculosis is a tuberculosis infection caused by infectious bacteria that are resistant to treatment of first line anti tubercular drugs. Insufficient drug delivery is the main cause of drug resistance. Some tuberculosis infectious bacteria are also resistant to second line drugs referred as extensively drug resistant TB. Beginning of antibiotic treatment, some strains of TB bacteria produced resistance to specific drugs through genetic changes. Multi drug resistance require second line drug which are less effective and more active. 9% of MDR-TB are resistant to one of the drugs in the group comes under XDR-TB. Increase in resistance level in tuberculosis strain causes complication for public health to control tuberculosis.


  • Multi drug- resistance TB (MDR-TB)
  • Extensively drug resistance TB(XDR-TB)
  • Laboratory handling
  • Statistics of drug resistance TB
  • Drug susceptibility testing
  • Gen expert test

Related Conference of Drug resistant tuberculosis (MDR-TB)

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Drug resistant tuberculosis (MDR-TB) Conference Speakers

Recommended Sessions

Related Journals

Are you interested in